Neurocrine Biosciences (NBIX) Misses Q4 EPS by 54c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $154.44 -0.03%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of $0.04, $0.54 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $303.5 million versus the consensus estimate of $320 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
